Calidi Biotherapeutics, Inc.
Symbol: CLDI (NYSE)
0.64
▼ (-16.57%) -0.128
Company Description:
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
Key Stats
- Today's Open: $0.73
- Today's High: $0.766
- Today's Low: $0.6
- Today's Volume: 2.75M
- Yesterday Close: $0.7719
- Yesterday High: $0.8151
- Yesterday Low: $0.748
- Yesterday Volume: 2.36M
- Last Min Volume: 0
- Last Min High: $0.644
- Last Min Low: $0.637
- Last Min VWAP: $0
Company Profile
- Name: Calidi Biotherapeutics, Inc.
- Website: https://www.calidibio.com
- Listed Date: 2023-09-13
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001855485
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $25.20M
- Round Lot: 100
- Outstanding Shares: 34.52M
- Asset Type: CS
RECENT FILINGS FOR CLDI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-25 | 8-K | View |
| 2025-07-18 | S-3 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-11 | EFFECT | View |
| 2025-07-11 | 8-K | View |
| 2025-07-10 | 424B3 | View |
| 2025-07-10 | 424B3 | View |
| 2025-07-10 | 8-K | View |
| 2025-07-03 | S-1 | View |
| 2025-05-23 | DEFA14A | View |
| 2025-05-23 | DEF 14A | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-14 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-12 | PRE 14A | View |
| 2025-05-02 | 8-K | View |
| 2025-04-25 | 4 | View |
Latest News on CLDI